A phase I study of SAR-247799 for cardiovascular disorders
Latest Information Update: 15 Nov 2016
At a glance
- Drugs SAR 247799 (Primary)
- Indications Cardiovascular disorders
- Focus Adverse reactions
- 15 Nov 2016 New trial record
Latest Information Update: 15 Nov 2016